GW&K Investment Management LLC Has $48.78 Million Stake in West Pharmaceutical Services Inc. (NYSE:WST)

GW&K Investment Management LLC trimmed its stake in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 0.1% during the third quarter, Holdings Channel.com reports. The firm owned 343,932 shares of the medical instruments supplier’s stock after selling 252 shares during the period. GW&K Investment Management LLC’s holdings in West Pharmaceutical Services were worth $48,777,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in WST. FMR LLC lifted its position in shares of West Pharmaceutical Services by 41.3% during the first quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock worth $88,000 after purchasing an additional 232 shares in the last quarter. Zions Bancorporation N.A. lifted its position in shares of West Pharmaceutical Services by 3.0% during the second quarter. Zions Bancorporation N.A. now owns 5,242 shares of the medical instruments supplier’s stock worth $656,000 after purchasing an additional 155 shares in the last quarter. First Citizens Bank & Trust Co. acquired a new position in shares of West Pharmaceutical Services during the second quarter worth approximately $627,000. First Hawaiian Bank lifted its position in shares of West Pharmaceutical Services by 29.2% during the second quarter. First Hawaiian Bank now owns 2,239 shares of the medical instruments supplier’s stock worth $280,000 after purchasing an additional 506 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its position in shares of West Pharmaceutical Services by 1.4% during the second quarter. Oregon Public Employees Retirement Fund now owns 29,970 shares of the medical instruments supplier’s stock worth $3,751,000 after purchasing an additional 424 shares in the last quarter. Institutional investors own 91.07% of the company’s stock.

Shares of WST traded down $0.06 on Friday, reaching $147.73. 520,762 shares of the company’s stock were exchanged, compared to its average volume of 368,027. The company has a current ratio of 3.00, a quick ratio of 2.31 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $10.87 billion, a P/E ratio of 52.57, a price-to-earnings-growth ratio of 3.34 and a beta of 1.25. The business has a 50 day moving average price of $142.41 and a two-hundred day moving average price of $132.19. West Pharmaceutical Services Inc. has a 12 month low of $91.75 and a 12 month high of $152.10.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.08. The business had revenue of $456.10 million during the quarter, compared to the consensus estimate of $450.03 million. West Pharmaceutical Services had a net margin of 12.82% and a return on equity of 16.66%. West Pharmaceutical Services’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 earnings per share. Equities research analysts predict that West Pharmaceutical Services Inc. will post 3.14 EPS for the current year.

A number of brokerages have recently issued reports on WST. ValuEngine lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Bank of America upgraded shares of West Pharmaceutical Services from an “underperform” rating to a “neutral” rating in a research report on Friday, July 26th. Finally, Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $160.00 target price on the stock in a research report on Sunday, November 3rd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $131.39.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Story: Initial Public Offering (IPO)

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.